PEDIATRICS Vol. 108 No. 1 July 2001, p. e12
ELECTRONIC ARTICLE:
Neutrophil CD11b Expression and Circulating Interleukin-8 as
Diagnostic Markers for Early-Onset Neonatal Sepsis
Received Oct 11, 2000; accepted Feb 12, 2001.
,
, and
, ¶
From the * Hospital for Children and Adolescents, University of
Helsinki, Finland; Objective. To assess neutrophil CD11b
and circulating interleukin 8 (IL-8) as markers of early-onset
infection in neonates.
Methods. The study comprised 39 neonates, with a
gestational age of 29 to 41 weeks, suspected of infection within 48 hours of life. Neutrophil surface expression of CD11b was quantified
with flow cytometry and plasma IL-8 with an enzyme-linked immunosorbent assay. Both data were available from 35 of 39 neonates. Serum C-reactive protein was determined at initial evaluation and, later, on
the basis of the clinical picture. Neonates were allocated retrospectively into 2 groups. In the sepsis group
(N = 22), 4 had culture-proven sepsis, and 14 had
an antenatal risk factor for infection. In the possible-infection group
(N = 13), each neonate had a noninfective disorder,
but co-occurring infection remained a possibility. Twelve healthy term
infants served as controls.
Results. CD11b expression and IL-8 levels both increased
in order of sepsis > possible infection > healthy.
Sensitivity and specificity by the CD11b test for sepsis were equal, at
1.00, and those by the IL-8 test 0.91 and 1.00, respectively; 6 (17.1%) of the 35 neonates had CD11b and IL-8 below cutoff
levels.
Conclusions. Measuring neutrophil CD11b expression and
circulating IL-8 provides a means to identify early-onset neonatal
sepsis. The findings may be helpful in planning strategies to safely
reduce the use of antimicrobials in neonates.
Department of Bacteriology and Immunology,
Haartman Institute, University of Helsinki, Finland; § Department of
Obstetrics and Gynecology, University of Helsinki, Finland;
Rheumatism Foundation Hospital, Heinola, Finland; ¶ Department of
Medicine, Division of Infectious Diseases, University of Helsinki,
Finland.
This article has been cited by other articles:
![]() |
P C Ng Diagnostic markers of infection in neonates Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2004; 89(3): F229 - F235. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chiesa, A. Panero, J. F. Osborn, A. F. Simonetti, and L. Pacifico Diagnosis of Neonatal Sepsis: A Clinical and Laboratory Challenge Clin. Chem., February 1, 2004; 50(2): 279 - 287. [Full Text] [PDF] |
||||
![]() |
A. Malik, C. P. S. Hui, R. A. Pennie, and H. Kirpalani Beyond the Complete Blood Cell Count and C-Reactive Protein: A Systematic Review of Modern Diagnostic Tests for Neonatal Sepsis Arch Pediatr Adolesc Med, June 1, 2003; 157(6): 511 - 516. [Abstract] [Full Text] [PDF] |
||||







